The University of Chicago Header Logo

Connection

Jozef Madzo to Urinary Bladder Neoplasms

This is a "connection" page, showing publications Jozef Madzo has written about Urinary Bladder Neoplasms.
Connection Strength

0.172
  1. A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy. Clin Cancer Res. 2023 06 01; 29(11):2052-2065.
    View in: PubMed
    Score: 0.172
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.